Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan

References

• Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;304:1288–90. doi:10.1016/S0140-6736(74)90144-5.
   Google Scholar
• Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2007;56:1–40.
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control. Varicella vaccination in the European Union. 2015 Feb 4. [accessed 2018 Feb 5]. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Varicella-Guidance-2015.pdf.
   Google Scholar
• National Centre for Immunisation Research & Surveillance. Varicella-zoster (chickenpox) vaccines for Australian children. National Centre for Immunisation Research & Surveillance Fact sheet. 2015 Jul [accessed 2018 Feb 5]. http://www.ncirs.edu.au/assets/provider_resources/fact-sheets/varicella-fact-sheet.pdf.
   Google Scholar
• Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF. Changing varicella epidemiology in active surveillance sites–United States, 1995-2005. J Infect Dis. 2008;197(Suppl 2):S71–5. doi:10.1086/522156.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics. 2006;117:e1070–7. doi:10.1542/peds.2005-2085.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137:e20153741. doi:10.1542/peds.2015-3741.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program —United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2016;65:902–05. doi:10.15585/mmwr.mm6534a4.
   PubMed Web of Science ®Google Scholar
• Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15:645–57. doi:10.1080/21645515.2018.1546525.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Kawamura Y, Ohashi M, Yoshikawa A, Ihira M, Yahata Y, Kamiya H, Tanaka-Taya K, Yoshikawa T. Universal varicella vaccine immunization in Japan. Vaccine. 2017;35:4936–41. doi:10.1016/j.vaccine.2017.07.090.
   PubMedGoogle Scholar
• Ozaki T, Asano Y. Development of varicella vaccine in Japan and future prospects. Vaccine. 2016;34:3427–33. doi:10.1016/j.vaccine.2016.04.059.
   PubMed Web of Science ®Google Scholar
• National institute of infectious diseases. Survey of infectious disease. [accessed 2018 Feb 5]. https://www.niid.go.jp/niid/ja/survei/2085-idwr/ydata/7314-report-jb2016.html.
   Google Scholar
• Lopez AS, LaClair B, Buttery V, Zhang Y, Rosen J, Taggert E, Robinson S, Davis M, Waters C, Thomas CA, et al. Varicella outbreak surveillance in schools in sentinel jurisdictions, 2012–2015. J Pediatric Infect Dis Soc. 2019;8:122–27. doi:10.1093/jpids/piy010.
   PubMed Web of Science ®Google Scholar
• Thomas CA, Shwe T, Bixler D, Del Rosario M, Grytdal S, Wang C, Haddy LE, Bialek SR. Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students. Pediatr Infect Dis J. 2014;33:1164–68. doi:10.1097/INF.0000000000000444.
   PubMed Web of Science ®Google Scholar
• Tamhane AR, Westfall AO, Burkholder GA, Cutter GR. Prevalence odds ratio versus prevalence ratio: choice comes with consequences. Stat Med. 2016;35:5730–35. doi:10.1002/sim.7059.
   PubMed Web of Science ®Google Scholar
• Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T. Implementing universal varicella vaccination in Europe: the path forward. Pediatr Infect Dis J. 2019;38:181–88. doi:10.1097/INF.0000000000002233.
   PubMed Web of Science ®Google Scholar
• Hecht J, Siedler A. The epidemiology of varicella disease in Germany after introduction of a vaccination recommendation: analysis of mandatory and sentinel data between 2002 and 2014. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60:118–26. doi:10.1007/s00103-016-2475-8.
   PubMed Web of Science ®Google Scholar
• Rieck T, Feig M, An der Heiden M, Siedler A, Wichmann O. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Euro Surveill. 2017;22:30521. doi:10.2807/1560-7917.ES.2017.22.17.30521.
   PubMedGoogle Scholar
• Cenoz MG, Martínez-Artola V, Guevara M, Ezpeleta C, Barricarte A, Castilla J. Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain. Hum Vaccin Immunother. 2013;9:1172–76. doi:10.4161/hv.23451.
   PubMed Web of Science ®Google Scholar
• Marinelli I, van Lier A, de Melker H, Pugliese A, van Boven M. Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus. Epidemics. 2017;19:1–12. doi:10.1016/j.epidem.2016.11.001.
   PubMed Web of Science ®Google Scholar
• Gershon AA 1, LaRussa P, Steinberg S, Mervish N, SH L, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis. 1996;173:450–53. doi:10.1093/infdis/173.2.450.
   PubMed Web of Science ®Google Scholar
• Vossen MT, Gent MR, Weel JF, de Jong MD, van Lier RA, Kuijpers TW. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus. J Infect Dis. 2004;190:72–82. doi:10.1086/421277.
   PubMed Web of Science ®Google Scholar
• Kamiya H, Asano Y, Ozaki T, Baba K, Kumagai T, Nagai T, Shiraki K. Varicella vaccine potency and stability during transport and delivery. Kansenshogaku Zasshi. 2011;85:161–65. doi:10.11150/kansenshogakuzasshi.85.161.
   PubMedGoogle Scholar
• Ozaki T, Nishimura N, Kajita Y. Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic. Vaccine. 2000;18:2375–80. doi:10.1016/S0264-410X(00)00016-5.
   PubMed Web of Science ®Google Scholar
• Ozaki T, Nisimura N, Gotoh K, Funahashi K. A study for the necessity of virus titer of varicella vaccine presently used. Kansenshogaku Zashi. 2012;86:749–54. doi:10.11150/kansenshogakuzasshi.86.749.
   PubMedGoogle Scholar
• Watanabe M, Ochiai H, Ito M, Negoro M, Suga S, Ihara T. Laboratory diagnosis of breakthrough varicella in children. Pediatr Infect Dis J. 2017;36:560–63. doi:10.1097/INF.0000000000001475.
   PubMed Web of Science ®Google Scholar
• Kavaliotis J, Petridou S, Karabaxoglou D. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis. 2003;7:274–77. doi:10.1016/S1201-9712(03)90106-8.
   PubMedGoogle Scholar
• Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9:361–81. doi:10.1128/CMR.9.3.361.
   PubMed Web of Science ®Google Scholar
• Ludwig B, Kraus FB, Allwinn R, Keim S, Doerr HW, Buxbaum S. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination. Infection. 2006;34:222–26. doi:10.1007/s15010-006-5616-9.
   PubMed Web of Science ®Google Scholar
• Zerboni L, Nader S, Aoki K, Arvin AM. Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine. J Infect Dis. 1998;177:1701–04. doi:10.1086/517426.
   PubMed Web of Science ®Google Scholar
• Sauerbrei A, Schäfler A, Hofmann J, Schacke M, Gruhn B, Wutzler P. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test. Clin Vaccine Immunol. 2012;19:1261–68. doi:10.1128/CVI.00183-12.
   PubMedGoogle Scholar
• Sauerbrei A, Wutzler P. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol. 2006;44:3094–97. doi:10.1128/JCM.00719-06.
   PubMed Web of Science ®Google Scholar
• Otani N, Tanaka M, Maeda K, Gomi Y, Nakajima K, Tanimura S, Takesue Y, Shima M, Okuno T. Varicella zoster virus antibody detection: a comparison of four commonly used techniques. J Infect Chemother. 2016;22:225–28. doi:10.1016/j.jiac.2015.12.018.
   PubMed Web of Science ®Google Scholar